SEC Form 4 · accession 0001144204-15-070883

Neurotrope, Inc. · NTRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director

Period of report

Nov 30, 2015

Accepted (ET)

Dec 15, 2015 · 12:31 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001513856

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Nov 30, 2015	C	1,192,605	$0.8385	A	2,192,605	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Convertible Preferred Stock^F2,F1,F3	$0.8385	Nov 30, 2015	C	1,000,000	D	—	—	Common Stock	1,192,605	0	I

F1In connection with the conversion of the Issuer's Series A Convertible Preferred Stock into shares of common stock, the Reporting Person's 1,000,000 shares of Series A Convertible Preferred Stock were converted into an aggregate of 1,192,605 shares of common stock. The conversion price was reduced from $1.00 to $0.8385 due to an anti-dilution adjustment.
F2These securities are held by the Reporting Person indirectly through Ramat Consulting and NTR21 Holdings, LLC. The Reporting Person is an affiliate of each of Ramat Consulting and NTR21 Holdings, LLC, and has sole power to vote or direct the vote, and to dispose or direct the disposition, of such shares of the Issuer's common stock.
F3The Series A Convertible Preferred Stock was convertible at any time and had no expiration date. The Series A Convertible Preferred Stock automatically converted into shares of common stock on November 30, 2015, upon the consent of the holders of at least a majority of the then outstanding shares of Series A Convertible Preferred Stock.

Exhibit List - Exhibit 24 - Power of Attorney